Bullish case
$35 to $39
More likely if May 2026 AUM strength persists, QQQ economics lift net revenue yield, active and fixed income flows stay positive, expenses remain controlled, and the market assigns IVZ a mid-teens earnings multiple.
Invesco Ltd. research snapshot
IVZ AI stock analysis currently reads Invesco as a leveraged asset management turnaround rather than a simple compounder. The company has large ETF, fixed income, active, money market, and private markets franchises, ending 2025 with $2.17 trillion of AUM and reporting preliminary May 2026 AUM of $2.45 trillion. The scenario forecast is mixed: adjusted earnings power and QQQ economics support the bull case, while fee pressure, market beta, leverage, preferred stock, and active product outflows keep investment certainty moderate. This page is for informational research only and is not investment advice.
Current price
$27.40
Market cap
$12.15 billion verified by price times Q1 2026 shares
AI score
62 / 100
Rating
Cyclical asset manager, improving flows, valuation discipline needed
Trend status
Short-term neutral to constructive, but still close to the 200-day trend line
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Invesco earns fees from ETFs, active equity, fixed income, alternatives, money market, model portfolios, and institutional mandates, with revenue tied to AUM levels and product mix. | Medium-high |
| Moat | The moat is strongest in QQQ, ETF distribution, global platform breadth, fixed income capability, and advisor relationships, but weaker in commoditized active products. | Medium |
| Management | Andrew Schlossberg became CEO in 2023 and is executing simplification, QQQ modernization, private markets partnerships, preferred stock reduction, and buybacks. | Medium-high |
| Financial trend | FY2025 operating revenue was $6.377 billion, adjusted EPS was $2.03, ending AUM was $2.17 trillion, and Q1 2026 adjusted EPS improved to $0.57. | High |
| Valuation | At $27.40 and $2.13 run-rate EPS from Q1 2026 annualized earnings, IVZ trades near 12.86x earnings, 1.25x book value, and a 14.38% FCF yield using StockAnalysis per-share data. | Medium |
| Technical trend | Moving average signals are mixed: Investing.com shows neutral RSI and price below the 200-day average, while Barchart shows price above several medium-term averages. | Medium |
| Risk level | Main risks are market drawdowns, outflows, fee compression, debt and preferred stock burden, active manager underperformance, regulation, and expense inflation. | Medium-high |
| AI confidence | Descriptive confidence is high because filings and market data are available. Forecast confidence is lower because IVZ is highly sensitive to markets and flows. | High data confidence |
| Investment certainty | The stock can work if AUM, QQQ revenue, margins, and capital returns keep improving, but it is not a high certainty compounder at any price. | Medium-low |
IVZ AI stock forecast
The IVZ AI stock forecast uses scenario math around the $27.40 July 7, 2026 price reference, $2.13 annualized Q1 2026 EPS, and a three-year earnings multiple framework. The audited model produced a bearish area near $15.60, a base area near $26.40, and a bullish area near $37.60 before dividends.
$35 to $39
More likely if May 2026 AUM strength persists, QQQ economics lift net revenue yield, active and fixed income flows stay positive, expenses remain controlled, and the market assigns IVZ a mid-teens earnings multiple.
$25 to $28
More likely if adjusted EPS grows modestly, AUM stays near current levels, buybacks offset dilution, fee pressure remains manageable, and IVZ trades near an 11x earnings multiple.
$14 to $17
More likely if markets weaken, net flows reverse, QQQ revenue benefit disappoints, debt and preferred capital constrain flexibility, or investors discount adjusted earnings more heavily.
IVZ AI technical analysis
IVZ AI technical analysis is mixed as of the July 8, 2026 cutoff. StockAnalysis showed IVZ at $27.40 on July 7, 2026. Investing.com listed RSI(14) at 52.289, MACD at 0.190, 50-day moving average at $26.85, 200-day moving average at $27.63, and a Fibonacci pivot near $27.50. Barchart showed 20-day, 50-day, 100-day, and 200-day averages from $25.58 to $27.55, with 14-day relative strength near 51.03.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $27.40 | StockAnalysis July 7, 2026 market close used for the price reference. |
| Immediate support | $26.15 to $26.85 | ChartMill listed support near $26.15, and Investing.com placed the 50-day moving average near $26.85. |
| Pivot zone | $27.40 to $27.55 | The current close, Investing.com Fibonacci pivot near $27.50, and Barchart 20-day average near $27.55 cluster in this area. |
| Near resistance | $29.40 to $30.00 | ChartMill listed resistance near $29.44. A sustained move above that area would confirm better demand. |
| 50-day moving average | $26.85 to $27.28 | Investing.com and Barchart place the 50-day average in this range, making it a useful short to medium-term trend marker. |
| 200-day moving average | $25.58 to $27.63 | The feed split is material: Investing.com places the 200-day above price while Barchart places it below price. |
| Momentum | RSI near 51 to 52 | Both Investing.com and Barchart show neutral momentum rather than an overbought or oversold extreme. |
| Volume and volatility | Average volume near 5.3 million, ATR near $0.95 | Barchart shows active liquidity and roughly mid-single-digit two-week average true range as a percent of price. |
| Invalidation | Close below $26.15 | A close below the cited support area would weaken the short-term recovery setup and shift focus to lower range support. |
IVZ AI trading strategy
The IVZ AI trading strategy below is a rules-based research framework, not personalized advice. It combines market regime, AUM trend, fund flows, QQQ economics, capital return, and technical confirmation.
Watch for IVZ to hold above the $27.40 to $27.55 pivot zone and then clear $29.40 to $30.00 with improving AUM releases, positive long-term net flows, and stable expense guidance.
A failed breakout back below the pivot zone or a close below $26.15 should reduce setup confidence.
If IVZ pulls back toward $26.15 to $26.85 without a new market drawdown or flow shock, compare price behavior with AUM releases, ETF demand, fixed income flows, and credit spreads.
Do not average down if broad markets are falling, active outflows accelerate, or debt and preferred capital concerns return.
Track monthly AUM, long-term net flows, QQQ revenue contribution, adjusted operating margin, cash, debt, preferred stock balance, buybacks, dividend coverage, and active fund performance.
Position sizing should reflect that IVZ is partly a levered expression of markets, flows, and investor appetite for asset manager equities.
Investment research summary
Invesco sells investment access, portfolio management, ETF exposure, active strategies, fixed income products, alternatives, and institutional solutions. Clients pay for distribution, product choice, brand trust, and investment process.
The moat is narrow to moderate overall. QQQ and ETF distribution have stronger brand and scale advantages, while many active strategies face substitutable products, fee pressure, and performance-sensitive flows.
The thesis fails if markets fall, clients redeem, active performance disappoints, fee rates keep compressing, QQQ benefits are offset by costs, or debt and preferred stock limit capital returns.
Andrew Schlossberg has emphasized focus, scale, balance sheet repair, QQQ modernization, and private markets partnerships. The execution test is whether those moves convert higher AUM into durable per-share earnings.
Asset management benefits from retirement savings, ETF adoption, model portfolios, alternatives, and global wealth growth. The offset is that passive products pressure fees and weak markets can reverse AUM quickly.
IVZ screens inexpensive on adjusted earnings, book value, dividend yield, and FCF yield, but that valuation partly reflects cyclicality, impairment history, leverage, and lower confidence in normalized earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| IVZ price reference | $27.40 at July 7, 2026 close | StockAnalysis | July 8, 2026 |
| Market capitalization | $12.15 billion calculated from $27.40 price and 443.3 million Q1 2026 shares | Pineify financial_rigor.py using Invesco Q1 2026 share count | July 8, 2026 |
| FY2025 operating revenue | $6.377 billion | Invesco 2025 Annual Report | July 8, 2026 |
| FY2025 adjusted EPS | $2.03 | Invesco 2025 Annual Report | July 8, 2026 |
| FY2025 ending AUM | $2.1699 trillion | Invesco 2025 Annual Report | July 8, 2026 |
| May 2026 preliminary AUM | $2.4539 trillion | Invesco Corporate AUM release | July 8, 2026 |
| Q1 2026 adjusted EPS | $0.57 | Invesco Q1 2026 Results | July 8, 2026 |
| Q1 2026 cash and debt | $806.9 million cash and $1.9667 billion debt | Invesco Q1 2026 Results | July 8, 2026 |
| Q1 2026 common shares outstanding | 443.3 million | Invesco Q1 2026 Results | July 8, 2026 |
| Technical indicators | RSI 52.289, MACD 0.190, 50-day MA $26.85, 200-day MA $27.63 | Investing.com | July 8, 2026 |
| Per-share valuation inputs | BVPS $21.98, FCF per share $3.94, dividend per share $0.86 | StockAnalysis statistics | July 8, 2026 |
| Moving averages and ATR | 20-day MA $27.55, 50-day MA $27.28, 200-day MA $25.58, 14-day ATR $0.95 | Barchart | July 8, 2026 |
This IVZ AI stock analysis is an informational research tool, not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available public data as of July 8, 2026 and may be wrong if markets, AUM, flows, fees, earnings, leverage, or valuation multiples change.